Dietary Factors in Retinal Aging and Macular Disease
视网膜衰老和黄斑疾病的饮食因素
基本信息
- 批准号:9769030
- 负责人:
- 金额:$ 50.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAge related macular degenerationAgingAmericanAmerican dietAnimal ModelAnimalsAntioxidantsAtrophicBiochemicalBlindnessCarotenoidsCellsClinical ResearchDataDeveloped CountriesDeveloping CountriesDevelopmentDietDietary FactorsDietary FatsDietary HistoryDiseaseDisease ProgressionElderlyEvolutionEyeEye diseasesFatty acid glycerol estersFundusGeneticGoalsHealthHigh Fat DietHistologicHumanIntakeInterventionJointsKnowledgeLeadLegal BlindnessLifeLipofuscinLongevityLuteinMacacaMacaca mulattaMeasurementMeasuresModalityModelingMolecularMonkeysMorphologyNatureNutrientNutritionalOmega-3 Fatty AcidsOutcomePathologyPatientsPigmentsPlayPrevalencePreventionPrimatesProcessPublic HealthResearchResourcesRetinaRetinalRetinal DiseasesRiskRisk FactorsRoleSmokingStructureTestingTherapeutic InterventionThickWorkage relatedbasecomparison groupdietary supplementsdisorder of macula of retinadisorder preventioneffective therapyfovea centralisgeographic atrophygood dietimaging modalityin vivoin vivo imagingindexingmaculanew therapeutic targetnonhuman primatenormal agingnutritionprematurepreventretinal imagingstandard of caresugartranslational modelzeaxanthin
项目摘要
PROJECT SUMMARY
Age-related macular degeneration (AMD) is the most common cause of legal blindness in the elderly in
developed countries and a leading cause of blindness worldwide. A growing body of evidence supports
protective roles for nutritional factors, including the carotenoids lutein (L) and zeaxanthin (Z), which
concentrate in the fovea to form the macular pigment, and omega-3 (ω-3) fatty acids. However, the typical
American diet is low in these nutrients and therefore, there is an urgent need to better understand the role that
these nutrients play in retinal aging and disease and their potential to reduce the risk of AMD. Only nonhuman
primates with a macula and fovea provide an accurate translational model to address this issue. We have
available three exceptional resources: groups of aging macaque monkeys with life-long controlled diets devoid
of L and Z and providing either adequate or deficient ω-3 fatty acid content, and showing signs of early AMD;
aging monkeys fed diets high in fat and sugar and mimicking the typical American diet; and a large colony of
aging macaques fed a healthy diet to address the effects of normal aging. Comparison of these groups of
animals provide a truly unique opportunity to understand the roles of dietary factors in retinal aging and
disease. This proposal will use these unique resources to address the following aims:
1) Define the relationships in vivo among macular pigment and metrics of macular health in primate
eyes across the lifespan and across a wide range of dietary histories including including life-long
absence of L/Z.
2) Define the relationships ex vivo among L/Z, the molecular components of lipofucsin, retinal
morphology and diet-related retinal pathology, and correlate these findings to the corresponding
measurements obtained in vivo.
Collectively, these aims will quantify longitudinal changes in macular pigment and the concentration and
distribution of components of lipofuscin in the retina and RPE, will characterize changes in retinal structure with
age and retinal disease, and will correlate these measurements between in vivo and ex vivo assessment
modalities to enhance the interpretation of in vivo imaging.
We expect the outcome of the proposed work to have a significant impact on the understanding of the role
of macular pigment and dietary fat in aging and retinal diseases including AMD. We also expect to provide data
critical to the current controversy on the role of lipofuscin components in AMD. Our studies also will provide
exceptional opportunities to examine the evolution of retinal aging and disease, as well as to obtain high quality
clinicopathological correlations in multiple metrics of retinal health. Because of the highly translational nature
of these nonhuman primate studies, they are expected to have a significantly high impact on understanding the
role of nutrition in maintaining retinal health and prevention or treatment of retinal disease.
项目总结
老年性黄斑变性(AMD)是老年人法定失明的最常见原因
这是发达国家和世界范围内导致失明的主要原因。越来越多的证据支持
对营养因素的保护作用,包括类胡萝卜素叶黄素(L)和玉米黄质(Z),它们
集中在中心凹形成黄斑色素,以及欧米茄-3(ω-3)脂肪酸。然而,典型的
美国人的饮食中这些营养素含量很低,因此,迫切需要更好地了解
这些营养素在视网膜老化和疾病中发挥作用,并有可能降低患AMD的风险。只有非人类
有黄斑和中心凹的灵长类动物提供了一个准确的转换模型来解决这个问题。我们有
可用的三种特殊资源:一群终生受控饮食的老年猕猴缺乏
L和Z型,ω-3脂肪酸含量适中或不足,有早期AMD征象;
年迈的猴子喂食高脂肪和高糖的食物,并模仿典型的美国饮食;以及一大群
老化的猕猴喂食健康的饮食,以解决正常衰老的影响。这几组人的比较
动物提供了一个真正独特的机会来了解饮食因素在视网膜老化和
疾病。该提案将利用这些独特的资源来实现以下目标:
1)确定灵长类动物黄斑色素与黄斑健康指标之间的活体关系
着眼于一生和广泛的饮食历史,包括终身饮食
L/Z缺席。
2)明确L/Z、脂褐素分子组成、视网膜
形态和饮食相关的视网膜病理,并将这些发现与相应的
活体测量。
总而言之,这些目标将量化黄斑色素的纵向变化和浓度和
脂褐素成分在视网膜和RPE中的分布,将表征视网膜结构的变化
年龄和视网膜疾病,并将在体内和体外评估这些测量之间的相关性
增强活体成像解释的方式。
我们预计拟议工作的结果将对理解这一作用产生重大影响
黄斑色素和膳食脂肪在衰老和包括AMD在内的视网膜疾病中的作用。我们还希望提供数据
对于目前关于脂褐素成分在AMD中的作用的争议至关重要。我们的研究还将提供
检查视网膜老化和疾病演变的特殊机会,以及获得高质量
视网膜健康的多个指标之间的临床病理相关性。因为高度的翻译性
在这些非人类灵长类动物的研究中,他们预计将对理解
营养在维持视网膜健康和预防或治疗视网膜疾病中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTHA NEURINGER其他文献
MARTHA NEURINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTHA NEURINGER', 18)}}的其他基金
Nonhuman Primate Model of Inherited Photoreceptor Degeneration
遗传性感光器变性的非人类灵长类动物模型
- 批准号:
10717645 - 财政年份:2023
- 资助金额:
$ 50.07万 - 项目类别:
CALORIC RESTRICTION AND AGING IN NONHUMAN PRIMATE EYES
非人类灵长类动物眼睛的热量限制和衰老
- 批准号:
8357752 - 财政年份:2011
- 资助金额:
$ 50.07万 - 项目类别:
Evaluation of stem cell-derived retinal pigment epithelial cells for retinal dise
干细胞来源的视网膜色素上皮细胞对视网膜疾病的评价
- 批准号:
8215696 - 财政年份:2011
- 资助金额:
$ 50.07万 - 项目类别:
RETINOGEOGRAPHIC DISTRIBUTION OF SECRETED RETINOSCHISIN
分泌性视网膜分裂素的视网膜地理分布
- 批准号:
8357820 - 财政年份:2011
- 资助金额:
$ 50.07万 - 项目类别:
Evaluation of stem cell-derived retinal pigment epithelial cells for retinal dise
干细胞来源的视网膜色素上皮细胞对视网膜疾病的评价
- 批准号:
8608528 - 财政年份:2011
- 资助金额:
$ 50.07万 - 项目类别:
Evaluation of stem cell-derived retinal pigment epithelial cells for retinal dise
干细胞来源的视网膜色素上皮细胞对视网膜疾病的评价
- 批准号:
8445326 - 财政年份:2011
- 资助金额:
$ 50.07万 - 项目类别:
PILOT STUDY OF TUDCA DOSING AND PHARMACOKINETICS IN NONHUMAN PRIMATES
TUDCA 在非人类灵长类动物中的剂量和药代动力学试点研究
- 批准号:
8357872 - 财政年份:2011
- 资助金额:
$ 50.07万 - 项目类别:
CALORIC RESTRICTION AND AGING IN NONHUMAN PRIMATE EYES
非人类灵长类动物眼睛的热量限制和衰老
- 批准号:
8173209 - 财政年份:2010
- 资助金额:
$ 50.07万 - 项目类别:
TRANSFER & EXPRESSION OF THE GFP REPORTER GENE FOLLOWING SINGLE SUBRETINAL
转移
- 批准号:
8173313 - 财政年份:2010
- 资助金额:
$ 50.07万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 50.07万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 50.07万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 50.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 50.07万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 50.07万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 50.07万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 50.07万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 50.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 50.07万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 50.07万 - 项目类别: